Garrett Collins
About Garrett Collins
Garrett Collins serves as the Senior Director of Finance at BridgeBio, where he has worked since 2019. He holds a BA in Economics from Williams College and has extensive experience in financial operations within the biotechnology sector.
Work at BridgeBio
Garrett Collins has held the position of Senior Director of Finance at BridgeBio since 2019. In this role, he oversees financial operations and strategic planning within the organization. His responsibilities include managing budgets, forecasting financial performance, and ensuring compliance with financial regulations. His experience in the biotechnology sector contributes to the financial health and operational efficiency of BridgeBio.
Education and Expertise
Garrett Collins earned a Bachelor of Arts in Economics from Williams College, where he studied from 2000 to 2004. His educational background provides a strong foundation in economic principles and financial analysis. Prior to attending Williams College, he completed his studies at Middlesex School from 1997 to 2000. This academic experience supports his expertise in finance and operations within the biotechnology industry.
Background
Garrett Collins has a diverse professional background in finance and operations within the biotechnology sector. He began his career as a Clinical Trial Associate at Genentech from 2007 to 2009. He then transitioned to Cytokinetics, where he served as a Financial Operations Analyst from 2009 to 2014. Following this, he worked at BioMarin Pharmaceutical Inc. as Associate Director of Development Sciences Business Operations from 2014 to 2018. He briefly held the position of Director of Clinical Outsourcing at Denali Therapeutics from 2018 to 2019 before joining BridgeBio.
Professional Experience
Garrett Collins has accumulated significant experience in various roles across multiple organizations in the biotechnology field. His tenure at BioMarin Pharmaceutical Inc. as Associate Director involved overseeing business operations related to development sciences. At Cytokinetics, he focused on financial operations, while at Denali Therapeutics, he directed clinical outsourcing efforts. His career reflects a progression of responsibilities and expertise in financial management and operational strategy.